APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Enzalutamide Soft Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Enzalutamide Soft Capsules Industry Growth and Trends Forecast to 2032

Report ID 173988590127 December 2025103 pages

Choose your research edition.

Industry ResearchEnzalutamide Soft Capsules Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Enzalutamide Soft Capsules Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Enzalutamide Soft Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enzalutamide Soft Capsules Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Enzalutamide Soft Capsules Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Enzalutamide Soft Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Enzalutamide Soft Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Enzalutamide Soft Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Enzalutamide Soft Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Enzalutamide Soft Capsules include Aprazer Healthcare Pharma, Arechar Healthcare, Astellas Pharma, BDR Pharma, Glenmark Pharma, Intas Pharmaceuticals, Pfizer, Jiangsu Hansoh Pharmaceutical and Kelun Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Enzalutamide Soft Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Enzalutamide Soft Capsules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Enzalutamide Soft Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Enzalutamide Soft Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Enzalutamide Soft Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Enzalutamide Soft Capsules Market by Company

Aprazer Healthcare Pharma

Arechar Healthcare

Astellas Pharma

BDR Pharma

Glenmark Pharma

Intas Pharmaceuticals

Pfizer

Jiangsu Hansoh Pharmaceutical

Kelun Pharmaceutical

Qilu Pharmaceutical

PuraCap Pharmaceuticals

Shenyang Hongqi Pharmaceutical

Yichang Humanwell Pharmaceutical

Enzalutamide Soft Capsules Segment by Type

Original Drug

Generic Drug

Enzalutamide Soft Capsules Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Enzalutamide Soft Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzalutamide Soft Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enzalutamide Soft Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzalutamide Soft Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Enzalutamide Soft Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Enzalutamide Soft Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Original Drug Table 2. Major Company of Generic Drug Table 3. Global Enzalutamide Soft Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 5. Global Enzalutamide Soft Capsules Sales Market Share in Volume by Type (2021-2026) Table 6. Global Enzalutamide Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 7. Global Enzalutamide Soft Capsules Sales Market Share in Value by Type (2021-2026) Table 8. Global Enzalutamide Soft Capsules Price by Type (2021-2026) & (US$/Unit) Table 9. Global Enzalutamide Soft Capsules Sales by Type (2027-2032) & (K Units) Table 10. Global Enzalutamide Soft Capsules Sales Market Share in Volume by Type (2027-2032) Table 11. Global Enzalutamide Soft Capsules Sales by Type (2027-2032) & (US$ Million) Table 12. Global Enzalutamide Soft Capsules Sales Market Share in Value by Type (2027-2032) Table 13. Global Enzalutamide Soft Capsules Price by Type (2027-2032) & (US$/Unit) Table 14. North America Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 15. North America Enzalutamide Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 17. Europe Enzalutamide Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Enzalutamide Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 21. Latin America Enzalutamide Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Enzalutamide Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 24. Enzalutamide Soft Capsules Industry Trends Table 25. Enzalutamide Soft Capsules Industry Drivers Table 26. Enzalutamide Soft Capsules Industry Opportunities and Challenges Table 27. Enzalutamide Soft Capsules Industry Restraints Table 28. Global Enzalutamide Soft Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Enzalutamide Soft Capsules Revenue Market Share by Company (2021-2026) Table 30. Global Enzalutamide Soft Capsules Sales by Company (2021-2026) & (K Units) Table 31. Global Enzalutamide Soft Capsules Sales Share by Company (2021-2026) Table 32. Global Enzalutamide Soft Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Enzalutamide Soft Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Enzalutamide Soft Capsules Major Company Production Sites and Headquarters Table 35. Global Enzalutamide Soft Capsules Company, Product Type & Application Table 36. Global Enzalutamide Soft Capsules Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Enzalutamide Soft Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Enzalutamide Soft Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Enzalutamide Soft Capsules Sales by Region (2021-2026) & (K Units) Table 41. Global Enzalutamide Soft Capsules Sales Market Share in Volume by Region (2021-2026) Table 42. Global Enzalutamide Soft Capsules Sales by Region (2021-2026) & (US$ Million) Table 43. Global Enzalutamide Soft Capsules Sales Market Share in Value by Region (2021-2026) Table 44. Global Enzalutamide Soft Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Enzalutamide Soft Capsules Sales by Region (2027-2032) & (K Units) Table 46. Global Enzalutamide Soft Capsules Sales Market Share in Volume by Region (2027-2032) Table 47. Global Enzalutamide Soft Capsules Sales by Region (2027-2032) & (US$ Million) Table 48. Global Enzalutamide Soft Capsules Sales Market Share in Value by Region (2027-2032) Table 49. Global Enzalutamide Soft Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Enzalutamide Soft Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 52. Global Enzalutamide Soft Capsules Sales Market Share in Volume by Application (2021-2026) Table 53. Global Enzalutamide Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 54. Global Enzalutamide Soft Capsules Sales Market Share in Value by Application (2021-2026) Table 55. Global Enzalutamide Soft Capsules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Enzalutamide Soft Capsules Sales by Application (2027-2032) & (K Units) Table 57. Global Enzalutamide Soft Capsules Sales Market Share in Volume by Application (2027-2032) Table 58. Global Enzalutamide Soft Capsules Sales by Application (2027-2032) & (US$ Million) Table 59. Global Enzalutamide Soft Capsules Sales Market Share in Value by Application (2027-2032) Table 60. Global Enzalutamide Soft Capsules Price by Application (2027-2032) & (US$/Unit) Table 61. North America Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 62. North America Enzalutamide Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 64. Europe Enzalutamide Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Enzalutamide Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 68. Latin America Enzalutamide Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Enzalutamide Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 71. Aprazer Healthcare Pharma Company Information Table 72. Aprazer Healthcare Pharma Business Overview Table 73. Aprazer Healthcare Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Aprazer Healthcare Pharma Enzalutamide Soft Capsules Product Portfolio Table 75. Aprazer Healthcare Pharma Recent Development Table 76. Arechar Healthcare Company Information Table 77. Arechar Healthcare Business Overview Table 78. Arechar Healthcare Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Arechar Healthcare Enzalutamide Soft Capsules Product Portfolio Table 80. Arechar Healthcare Recent Development Table 81. Astellas Pharma Company Information Table 82. Astellas Pharma Business Overview Table 83. Astellas Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Astellas Pharma Enzalutamide Soft Capsules Product Portfolio Table 85. Astellas Pharma Recent Development Table 86. BDR Pharma Company Information Table 87. BDR Pharma Business Overview Table 88. BDR Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. BDR Pharma Enzalutamide Soft Capsules Product Portfolio Table 90. BDR Pharma Recent Development Table 91. Glenmark Pharma Company Information Table 92. Glenmark Pharma Business Overview Table 93. Glenmark Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Glenmark Pharma Enzalutamide Soft Capsules Product Portfolio Table 95. Glenmark Pharma Recent Development Table 96. Intas Pharmaceuticals Company Information Table 97. Intas Pharmaceuticals Business Overview Table 98. Intas Pharmaceuticals Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Intas Pharmaceuticals Enzalutamide Soft Capsules Product Portfolio Table 100. Intas Pharmaceuticals Recent Development Table 101. Pfizer Company Information Table 102. Pfizer Business Overview Table 103. Pfizer Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Pfizer Enzalutamide Soft Capsules Product Portfolio Table 105. Pfizer Recent Development Table 106. Jiangsu Hansoh Pharmaceutical Company Information Table 107. Jiangsu Hansoh Pharmaceutical Business Overview Table 108. Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Product Portfolio Table 110. Jiangsu Hansoh Pharmaceutical Recent Development Table 111. Kelun Pharmaceutical Company Information Table 112. Kelun Pharmaceutical Business Overview Table 113. Kelun Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Kelun Pharmaceutical Enzalutamide Soft Capsules Product Portfolio Table 115. Kelun Pharmaceutical Recent Development Table 116. Qilu Pharmaceutical Company Information Table 117. Qilu Pharmaceutical Business Overview Table 118. Qilu Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Qilu Pharmaceutical Enzalutamide Soft Capsules Product Portfolio Table 120. Qilu Pharmaceutical Recent Development Table 121. PuraCap Pharmaceuticals Company Information Table 122. PuraCap Pharmaceuticals Business Overview Table 123. PuraCap Pharmaceuticals Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. PuraCap Pharmaceuticals Enzalutamide Soft Capsules Product Portfolio Table 125. PuraCap Pharmaceuticals Recent Development Table 126. Shenyang Hongqi Pharmaceutical Company Information Table 127. Shenyang Hongqi Pharmaceutical Business Overview Table 128. Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Product Portfolio Table 130. Shenyang Hongqi Pharmaceutical Recent Development Table 131. Yichang Humanwell Pharmaceutical Company Information Table 132. Yichang Humanwell Pharmaceutical Business Overview Table 133. Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Product Portfolio Table 135. Yichang Humanwell Pharmaceutical Recent Development Table 136. North America Enzalutamide Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. North America Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 138. North America Enzalutamide Soft Capsules Sales Market Share by Country (2021-2026) Table 139. North America Enzalutamide Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 140. North America Enzalutamide Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 141. North America Enzalutamide Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Enzalutamide Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Enzalutamide Soft Capsules Market Share by Country (2021-2026) Table 144. North America Enzalutamide Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Enzalutamide Soft Capsules Market Share Forecast by Country (2027-2032) Table 146. Europe Enzalutamide Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Europe Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 148. Europe Enzalutamide Soft Capsules Sales Market Share by Country (2021-2026) Table 149. Europe Enzalutamide Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 150. Europe Enzalutamide Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Enzalutamide Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Enzalutamide Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Enzalutamide Soft Capsules Market Share by Country (2021-2026) Table 154. Europe Enzalutamide Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Enzalutamide Soft Capsules Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Enzalutamide Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 158. Asia-Pacific Enzalutamide Soft Capsules Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Enzalutamide Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 160. Asia-Pacific Enzalutamide Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Enzalutamide Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Enzalutamide Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Enzalutamide Soft Capsules Market Share by Country (2021-2026) Table 164. Asia-Pacific Enzalutamide Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Enzalutamide Soft Capsules Market Share Forecast by Country (2027-2032) Table 166. Latin America Enzalutamide Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Latin America Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 168. Latin America Enzalutamide Soft Capsules Sales Market Share by Country (2021-2026) Table 169. Latin America Enzalutamide Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 170. Latin America Enzalutamide Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Enzalutamide Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Enzalutamide Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Enzalutamide Soft Capsules Market Share by Country (2021-2026) Table 174. Latin America Enzalutamide Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Enzalutamide Soft Capsules Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Enzalutamide Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 178. Middle East and Africa Enzalutamide Soft Capsules Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Enzalutamide Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 180. Middle East and Africa Enzalutamide Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Enzalutamide Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Enzalutamide Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Enzalutamide Soft Capsules Market Share by Country (2021-2026) Table 184. Middle East and Africa Enzalutamide Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Enzalutamide Soft Capsules Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Enzalutamide Soft Capsules Distributors List Table 189. Enzalutamide Soft Capsules Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Enzalutamide Soft Capsules Image Figure 2. Global Enzalutamide Soft Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enzalutamide Soft Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Enzalutamide Soft Capsules Sales (2021-2032) & (K Units) Figure 5. Original Drug Image Figure 6. Global Original Drug Sales YoY Growth (2021-2032) & (K Units) Figure 7. Generic Drug Image Figure 8. Global Generic Drug Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Enzalutamide Soft Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Enzalutamide Soft Capsules Market Share by Type 2025 VS 2032 Figure 11. North America Enzalutamide Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 12. North America Enzalutamide Soft Capsules Sales Market Share in Value by Type in 2025 Figure 13. Europe Enzalutamide Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 14. Europe Enzalutamide Soft Capsules Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Enzalutamide Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Enzalutamide Soft Capsules Sales Market Share in Value by Type in 2025 Figure 17. Latin America Enzalutamide Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Enzalutamide Soft Capsules Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Enzalutamide Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Enzalutamide Soft Capsules Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Enzalutamide Soft Capsules Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Enzalutamide Soft Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Enzalutamide Soft Capsules Market Share by Application 2025 VS 2032 Figure 31. North America Enzalutamide Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 32. North America Enzalutamide Soft Capsules Sales Market Share in Value by Application in 2025 Figure 33. Europe Enzalutamide Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 34. Europe Enzalutamide Soft Capsules Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Enzalutamide Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Enzalutamide Soft Capsules Sales Market Share in Value by Application in 2025 Figure 37. Latin America Enzalutamide Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Enzalutamide Soft Capsules Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Enzalutamide Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Enzalutamide Soft Capsules Sales Market Share in Value by Application in 2025 Figure 41. North America Enzalutamide Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Enzalutamide Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Enzalutamide Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Enzalutamide Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Enzalutamide Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Enzalutamide Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Enzalutamide Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Enzalutamide Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Enzalutamide Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Enzalutamide Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Enzalutamide Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Enzalutamide Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Enzalutamide Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Enzalutamide Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Enzalutamide Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Enzalutamide Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Enzalutamide Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Enzalutamide Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Enzalutamide Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Enzalutamide Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Enzalutamide Soft Capsules Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Enzalutamide Soft Capsules Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Aprazer Healthcare Pharma
  • Arechar Healthcare
  • Astellas Pharma
  • BDR Pharma
  • Glenmark Pharma
  • Intas Pharmaceuticals
  • Pfizer
  • Jiangsu Hansoh Pharmaceutical
  • Kelun Pharmaceutical
  • Qilu Pharmaceutical
  • PuraCap Pharmaceuticals
  • Shenyang Hongqi Pharmaceutical
  • Yichang Humanwell Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Enzalutamide Soft Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Enzalutamide Soft Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Enzalutamide Soft Capsules Market by Type
  6. 1.3.1 Original Drug
  7. 1.3.2 Generic Drug
  8. 1.4 Global Enzalutamide Soft Capsules Market Size by Type
  9. 1.4.1 Global Enzalutamide Soft Capsules Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Enzalutamide Soft Capsules Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Enzalutamide Soft Capsules Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Enzalutamide Soft Capsules Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Enzalutamide Soft Capsules Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Enzalutamide Soft Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Enzalutamide Soft Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Enzalutamide Soft Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Enzalutamide Soft Capsules Industry Trends
  2. 2.2 Enzalutamide Soft Capsules Industry Drivers
  3. 2.3 Enzalutamide Soft Capsules Industry Opportunities and Challenges
  4. 2.4 Enzalutamide Soft Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Enzalutamide Soft Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Enzalutamide Soft Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Enzalutamide Soft Capsules Price (2021-2026)
  4. 3.4 Global Enzalutamide Soft Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Enzalutamide Soft Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Enzalutamide Soft Capsules Company, Product Type & Application
  7. 3.7 Global Enzalutamide Soft Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Enzalutamide Soft Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Enzalutamide Soft Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Enzalutamide Soft Capsules Tier 1, Tier 2, and Tier 3
4 Enzalutamide Soft Capsules Regional Status and Outlook
  1. 4.1 Global Enzalutamide Soft Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Enzalutamide Soft Capsules Historic Market Size by Region
  3. 4.2.1 Global Enzalutamide Soft Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Enzalutamide Soft Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Enzalutamide Soft Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Enzalutamide Soft Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Enzalutamide Soft Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Enzalutamide Soft Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Enzalutamide Soft Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Enzalutamide Soft Capsules by Application
  1. 5.1 Enzalutamide Soft Capsules Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Enzalutamide Soft Capsules Market Size by Application
  6. 5.2.1 Global Enzalutamide Soft Capsules Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Enzalutamide Soft Capsules Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Enzalutamide Soft Capsules Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Enzalutamide Soft Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Enzalutamide Soft Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Enzalutamide Soft Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Enzalutamide Soft Capsules Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Enzalutamide Soft Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aprazer Healthcare Pharma
  2. 6.1.1 Aprazer Healthcare Pharma Company Information
  3. 6.1.2 Aprazer Healthcare Pharma Business Overview
  4. 6.1.3 Aprazer Healthcare Pharma Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aprazer Healthcare Pharma Enzalutamide Soft Capsules Product Portfolio
  6. 6.1.5 Aprazer Healthcare Pharma Recent Developments
  7. 6.2 Arechar Healthcare
  8. 6.2.1 Arechar Healthcare Company Information
  9. 6.2.2 Arechar Healthcare Business Overview
  10. 6.2.3 Arechar Healthcare Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Arechar Healthcare Enzalutamide Soft Capsules Product Portfolio
  12. 6.2.5 Arechar Healthcare Recent Developments
  13. 6.3 Astellas Pharma
  14. 6.3.1 Astellas Pharma Company Information
  15. 6.3.2 Astellas Pharma Business Overview
  16. 6.3.3 Astellas Pharma Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Astellas Pharma Enzalutamide Soft Capsules Product Portfolio
  18. 6.3.5 Astellas Pharma Recent Developments
  19. 6.4 BDR Pharma
  20. 6.4.1 BDR Pharma Company Information
  21. 6.4.2 BDR Pharma Business Overview
  22. 6.4.3 BDR Pharma Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 BDR Pharma Enzalutamide Soft Capsules Product Portfolio
  24. 6.4.5 BDR Pharma Recent Developments
  25. 6.5 Glenmark Pharma
  26. 6.5.1 Glenmark Pharma Company Information
  27. 6.5.2 Glenmark Pharma Business Overview
  28. 6.5.3 Glenmark Pharma Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Glenmark Pharma Enzalutamide Soft Capsules Product Portfolio
  30. 6.5.5 Glenmark Pharma Recent Developments
  31. 6.6 Intas Pharmaceuticals
  32. 6.6.1 Intas Pharmaceuticals Company Information
  33. 6.6.2 Intas Pharmaceuticals Business Overview
  34. 6.6.3 Intas Pharmaceuticals Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Intas Pharmaceuticals Enzalutamide Soft Capsules Product Portfolio
  36. 6.6.5 Intas Pharmaceuticals Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Enzalutamide Soft Capsules Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Jiangsu Hansoh Pharmaceutical
  44. 6.8.1 Jiangsu Hansoh Pharmaceutical Company Information
  45. 6.8.2 Jiangsu Hansoh Pharmaceutical Business Overview
  46. 6.8.3 Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Product Portfolio
  48. 6.8.5 Jiangsu Hansoh Pharmaceutical Recent Developments
  49. 6.9 Kelun Pharmaceutical
  50. 6.9.1 Kelun Pharmaceutical Company Information
  51. 6.9.2 Kelun Pharmaceutical Business Overview
  52. 6.9.3 Kelun Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Kelun Pharmaceutical Enzalutamide Soft Capsules Product Portfolio
  54. 6.9.5 Kelun Pharmaceutical Recent Developments
  55. 6.10 Qilu Pharmaceutical
  56. 6.10.1 Qilu Pharmaceutical Company Information
  57. 6.10.2 Qilu Pharmaceutical Business Overview
  58. 6.10.3 Qilu Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Qilu Pharmaceutical Enzalutamide Soft Capsules Product Portfolio
  60. 6.10.5 Qilu Pharmaceutical Recent Developments
  61. 6.11 PuraCap Pharmaceuticals
  62. 6.11.1 PuraCap Pharmaceuticals Company Information
  63. 6.11.2 PuraCap Pharmaceuticals Business Overview
  64. 6.11.3 PuraCap Pharmaceuticals Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 PuraCap Pharmaceuticals Enzalutamide Soft Capsules Product Portfolio
  66. 6.11.5 PuraCap Pharmaceuticals Recent Developments
  67. 6.12 Shenyang Hongqi Pharmaceutical
  68. 6.12.1 Shenyang Hongqi Pharmaceutical Company Information
  69. 6.12.2 Shenyang Hongqi Pharmaceutical Business Overview
  70. 6.12.3 Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Product Portfolio
  72. 6.12.5 Shenyang Hongqi Pharmaceutical Recent Developments
  73. 6.13 Yichang Humanwell Pharmaceutical
  74. 6.13.1 Yichang Humanwell Pharmaceutical Company Information
  75. 6.13.2 Yichang Humanwell Pharmaceutical Business Overview
  76. 6.13.3 Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Product Portfolio
  78. 6.13.5 Yichang Humanwell Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Enzalutamide Soft Capsules Sales by Country
  2. 7.1.1 North America Enzalutamide Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Enzalutamide Soft Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Enzalutamide Soft Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Enzalutamide Soft Capsules Market Size by Country
  6. 7.2.1 North America Enzalutamide Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Enzalutamide Soft Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Enzalutamide Soft Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Enzalutamide Soft Capsules Sales by Country
  2. 8.1.1 Europe Enzalutamide Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Enzalutamide Soft Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Enzalutamide Soft Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Enzalutamide Soft Capsules Market Size by Country
  6. 8.2.1 Europe Enzalutamide Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Enzalutamide Soft Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Enzalutamide Soft Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Enzalutamide Soft Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Enzalutamide Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Enzalutamide Soft Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Enzalutamide Soft Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Enzalutamide Soft Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Enzalutamide Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Enzalutamide Soft Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Enzalutamide Soft Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Enzalutamide Soft Capsules Sales by Country
  2. 10.1.1 South America Enzalutamide Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Enzalutamide Soft Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Enzalutamide Soft Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Enzalutamide Soft Capsules Market Size by Country
  6. 10.2.1 South America Enzalutamide Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Enzalutamide Soft Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Enzalutamide Soft Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Enzalutamide Soft Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Enzalutamide Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Enzalutamide Soft Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Enzalutamide Soft Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Enzalutamide Soft Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Enzalutamide Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Enzalutamide Soft Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Enzalutamide Soft Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Enzalutamide Soft Capsules Value Chain Analysis
  2. 12.1.1 Enzalutamide Soft Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Enzalutamide Soft Capsules Production Mode & Process
  7. 12.2 Enzalutamide Soft Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Enzalutamide Soft Capsules Distributors
  10. 12.2.3 Enzalutamide Soft Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst